Health

Will a major **biotech firm** obtain **Phase 3 trial approval** for a universal flu vaccine based on mRNA technology by 2026?

Forecasting a major advance in infectious disease prevention using novel genetic technology.

Yes 0%Maybe 40%No 60%

5 total votes

Comments